Evidence-based recommendations on dostarlimab (Jemperli) for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency in adults.

NICE is unable to make a recommendation on brensocatib (Brinsupri) for treating non-cystic fibrosis bronchiectasis in people 12 years and over. This is because the company did not provide an evidence ...

Hundreds of thousands of people with type 2 diabetes could swap daily insulin injections for a once-a-week jab, following a NICE recommendation.

That is why AI is the right next topic for NICE Listens. The dialogue will explore how people want AI to be used in health ...

Evidence-based recommendation on finerenone (Kerendia) for treating symptomatic chronic heart failure with preserved or mildly reduced ejection fraction in adults ...